Literature DB >> 16314517

Inhibition of TFII-I-dependent cell cycle regulation by p53.

Zana P Desgranges1, Jinwoo Ahn, Maria B Lazebnik, Todd Ashworth, Caleb Lee, Richard C Pestell, Naomi Rosenberg, Carol Prives, Ananda L Roy.   

Abstract

The multifunctional transcription factor TFII-I is tyrosine phosphorylated in response to extracellular growth signals and transcriptionally activates growth-promoting genes. However, whether activation of TFII-I also directly affects the cell cycle profile is unknown. Here we show that under normal growth conditions, TFII-I is recruited to the cyclin D1 promoter and transcriptionally activates this gene. Most strikingly, upon cell cycle arrest resulting from genotoxic stress and p53 activation, TFII-I is ubiquitinated and targeted for proteasomal degradation in a p53- and ATM (ataxia telangiectasia mutated)-dependent manner. Consistent with a direct role of TFII-I in cell cycle regulation and cellular proliferation, stable and ectopic expression of wild-type TFII-I increases cyclin D1 levels, resulting in accelerated entry to and exit from S phase, and overcomes p53-mediated cell cycle arrest, despite radiation. We further show that the transcriptional regulation of cyclin D1 and cell cycle control by TFII-I are dependent on its tyrosine phosphorylation at positions 248 and 611, sites required for its growth signal-mediated transcriptional activity. Taken together, our data define TFII-I as a growth signal-dependent transcriptional activator that is critical for cell cycle control and proliferation and further reveal that genotoxic stress-induced degradation of TFII-I results in cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314517      PMCID: PMC1316948          DOI: 10.1128/MCB.25.24.10940-10952.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 2.  Back to the future with ubiquitin.

Authors:  Cecile M Pickart
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

4.  Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter.

Authors:  D W Kim; B H Cochran
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy.

Authors:  Christopher J Nelsen; Ryoko Kuriyama; Betsy Hirsch; Vivian C Negron; Wilma L Lingle; Melissa M Goggin; Michael W Stanley; Jeffrey H Albrecht
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

6.  Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6.

Authors:  R Parker; T Phan; P Baumeister; B Roy; V Cheriyath; A L Roy; A S Lee
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 7.  Minireview: Cyclin D1: normal and abnormal functions.

Authors:  Maofu Fu; Chenguang Wang; Zhiping Li; Toshiyuki Sakamaki; Richard G Pestell
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

8.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

9.  The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.

Authors:  Mark D'Amico; Kongming Wu; Maofu Fu; Mahadev Rao; Chris Albanese; Robert G Russell; Hanzhou Lian; David Bregman; Michael A White; Richard G Pestell
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

10.  MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.

Authors:  Yetao Jin; Shelya X Zeng; Hunjoo Lee; Hua Lu
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

View more
  18 in total

Review 1.  Signal-induced functions of the transcription factor TFII-I.

Authors:  Ananda L Roy
Journal:  Biochim Biophys Acta       Date:  2007-10-11

2.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.

Authors:  Maria B Lazebnik; Maria Isabel Tussie-Luna; Philip W Hinds; Ananda L Roy
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

Review 4.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.

Authors:  Ananda L Roy
Journal:  Gene       Date:  2011-10-21       Impact factor: 3.688

5.  Functional interrelationship between TFII-I and E2F transcription factors at specific cell cycle gene loci.

Authors:  Yong Shen; Rukiye Nar; Alex X Fan; Mahmoud Aryan; Mir A Hossain; Aishwarya Gurumurthy; Paul C Wassel; Ming Tang; Jianrong Lu; John Strouboulis; Jörg Bungert
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

Review 6.  Pathophysiology of TFII-I: Old Guard Wearing New Hats.

Authors:  Ananda L Roy
Journal:  Trends Mol Med       Date:  2017-04-28       Impact factor: 11.951

7.  Loss of cell surface TFII-I promotes apoptosis in prostate cancer cells stimulated with activated α₂ -macroglobulin.

Authors:  U K Misra; Y M Mowery; G Gawdi; S V Pizzo
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

8.  Essential role of the N-terminal region of TFII-I in viability and behavior.

Authors:  Jaume Lucena; Susana Pezzi; Ester Aso; Maria C Valero; Candelas Carreiro; Pierre Dubus; Adriana Sampaio; Maria Segura; Isabel Barthelemy; Marc Y Zindel; Nuno Sousa; José L Barbero; Rafael Maldonado; Luis A Pérez-Jurado; Victoria Campuzano
Journal:  BMC Med Genet       Date:  2010-04-19       Impact factor: 2.103

9.  Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.

Authors:  Iwona Fijalkowska; Deva Sharma; Carol J Bult; Sonye K Danoff
Journal:  BMC Res Notes       Date:  2010-07-20

10.  Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1.

Authors:  Tomás Racek; Sven Buhlmann; Franziska Rüst; Susanne Knoll; Vijay Alla; Brigitte M Pützer
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.